In our whole population-based study of NPC in Finland, we examined the expression of TLR1, TLR2, TLR4, TLR5, TLR7, and TLR9 in 150 tumours and analysed their pattern of expression according to EBV and HPV status, and clinical outcome. Here, TLR4 is linked to nasopharyngeal carcinoma.